Published in major journals, first or last author from Oslo University Hospital.
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Sci Transl Med, 13 (582)
DOI 10.1126/scitranslmed.abb0036, PubMed 33627483
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Sci Adv, 7 (8)
DOI 10.1126/sciadv.abe4038, PubMed 33608276
Constructive criticism or distortion of the humanitarian narrative? - Authors' reply
Lancet Glob Health, 9 (3), e255
DOI 10.1016/S2214-109X(20)30553-2, PubMed 33607025